Page last updated: 2024-11-05

ticlopidine and Lupus Erythematosus, Cutaneous

ticlopidine has been researched along with Lupus Erythematosus, Cutaneous in 2 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Lupus Erythematosus, Cutaneous: A form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute (= LUPUS ERYTHEMATOSUS, SYSTEMIC with skin lesions), subacute, and chronic (= LUPUS ERYTHEMATOSUS, DISCOID).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hewitt, C1
Carton, J1
Wakelin, S1
Reich, A1
Bialynicki-Birula, R1
Szepietowski, JC1

Other Studies

2 other studies available for ticlopidine and Lupus Erythematosus, Cutaneous

ArticleYear
Subacute cutaneous lupus erythematosus: is clopidogrel a trigger?
    Clinical and experimental dermatology, 2018, Volume: 43, Issue:5

    Topics: Aged; Clopidogrel; Humans; Lupus Erythematosus, Cutaneous; Male; Platelet Aggregation Inhibitors; Sk

2018
Drug-induced subacute cutaneous lupus erythematosus resulting from ticlopidine.
    International journal of dermatology, 2006, Volume: 45, Issue:9

    Topics: Acute Disease; Aged; Female; Fibrinolytic Agents; Humans; Lupus Erythematosus, Cutaneous; Thrombosis

2006